| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.15 | 0.0008 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.099 | 0.001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |